文献速递血管炎

意义未明克隆性造血与巨细胞动脉炎复发的关系

Clonal haematopoiesis of indeterminate potential and relapses in patients with GCA.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该前瞻性单中心队列研究纳入40例新诊断巨细胞动脉炎(GCA)患者,采用二代测序检测意义未明克隆性造血(CHIP)。中位随访26个月,17例(42%)在12个月内复发。多因素分析显示,诊断时眼部受累(OR 4.02,95%CI 1.19-13.56,P<0.025)和CHIP存在(OR 9.94,95%CI 2.98-33.17,P=0.0002)与12个月内复发独立相关。

要点

  • CHIP在45%的新诊断GCA患者中检出。
  • CHIP存在与12个月内GCA复发独立相关(OR 9.94)。
  • 诊断时眼部受累亦与复发独立相关(OR 4.02)。

核心结论

  • 在该探索性队列中,CHIP的存在与GCA复发相关,需进一步研究确认。

研究设计与样本

  • 前瞻性分析单中心新诊断GCA患者队列,共纳入40例患者,中位年龄73岁[67-80],女性20例(50%)。

主要发现

  • CHIP检出18例(45%),中位随访26[14-45]个月,17例(42%)在12个月内复发。
  • 多因素分析显示,诊断时眼部受累与12个月内复发独立相关(OR 4.02,95%CI 1.19-13.56,P<0.025)。
  • 多因素分析显示,CHIP存在与12个月内复发独立相关(OR 9.94,95%CI 2.98-33.17,P=0.0002)。

关键数值与推荐

  • CHIP定义为经二代测序在外周血单个核细胞中检测到的髓系恶性肿瘤相关基因变异,等位基因频率>2%。
  • 复发定义为诱导缓解后出现的归因于GCA的相关体征或症状和/或炎症综合征。
  • 主要结局为GCA诱导治疗后12个月内发生的复发。

临床怎么用

  • 对初诊GCA患者,可关注CHIP检测及眼部受累情况以辅助评估12个月内复发风险。

局限性

  • 本研究为单中心探索性队列,样本量较小,结论需进一步研究证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: GCA is the most common vasculitis after 50 years of age, responsive to steroids with frequent relapses. Our objective was to evaluate clonal haematopoiesis of indeterminate potential (CHIP) as a risk factor for relapse in GCA. METHODS: We prospectively analysed CHIP in a monocentric cohort of recently diagnosed GCA patients. CHIP was defined as a variant in a gene implicated in myeloid malignancies with allele frequency >2% detected in peripheral blood mononuclear cells by next-generation sequencing. Relapses were defined as GCA related signs or symptoms and/or inflammatory syndrome attributable to GCA after remission induction. The primary outcome was relapse occurring within 12 months of GCA induction treatment. RESULTS: We included 40 patients with 20 women (50%) of median age 73 years [67-80]. At diagnosis, 16 (40%) patients had ophthalmic involvement and 23 (57%) patients had large vessel involvement. CHIP was detected in 18 (45%) patients. During a median follow-up of 26 [14-45] months, 17 (42%) patients relapsed at 12 months. In multivariate analysis, baseline factors independently associated with GCA relapse at month 12 were ophthalmologic involvement at diagnosis (OR 4.02, 95% CI [1.19-13.56], P < 0.025) and the presence of CHIP (OR 9.94, 95% CI [2.98-33.17], P = 0.0002). CONCLUSION: The presence of CHIP is associated with GCA relapses in this exploratory cohort. Further studies are needed to confirm these findings.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Cellier O, Saadoun D, Hirsch P, et al. Clonal haematopoiesis of indeterminate potential and relapses in patients with GCA. Rheumatology (Oxford). 2026. PMID: 41992515. doi:10.1093/rheumatology/keag204

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。